MARKET

RDY

RDY

Dr Reddys Labs
NYSE
12.20
-0.07
-0.57%
After Hours: 12.20 0 0.00% 19:30 10/08 EDT
OPEN
12.07
PREV CLOSE
12.27
HIGH
12.29
LOW
11.99
VOLUME
3.83M
TURNOVER
--
52 WEEK HIGH
15.56
52 WEEK LOW
11.28
MARKET CAP
10.16B
P/E (TTM)
28.97
1D
5D
1M
3M
1Y
5Y
1D
Dr. Reddy’s Receives Two-Observation USFDA Form 483 After PAI at FTO-11
TipRanks · 16h ago
Dr Reddy's Says FDA Completed Pre-Approval Inspection At The FTO-11 Manufacturing Facility In Pydibhimavaram
Benzinga · 19h ago
Dr. Reddy’s Sets October 23 Date for Q2 FY27 Results and Global Earnings Call
TipRanks · 1d ago
Dr. Reddy’s U.S. Subsidiary Hit with Modest IRS Penalty, Assessed as Non‑Material
TipRanks · 3d ago
Weekly Report: what happened at RDY last week (0928-1002)?
Weekly Report · 3d ago
Analysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)
TipRanks · 10/01 15:10
Dr Reddy's Labs Price Target Raised to $1450.00/Share From $1040.00 by Citigroup
Dow Jones · 09/29 17:58
Dr Reddy's Labs Raised to Buy From Sell by Citigroup
Dow Jones · 09/29 17:58
More
About RDY
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Webull offers Dr Reddy's Laboratories Ltd (ADR) stock information, including NYSE: RDY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDY stock methods without spending real money on the virtual paper trading platform.